Prognostic factors in patients with secondary hemophagocytic lymphohistioc ytosis in a Chinese cohort Yuanyuan PeiJihong ZhuYin Su Original Article 24 January 2024 Pages: 695 - 703
A multicentre ambispective observational study into the incidence and clinical management of aplastic anaemia in Spain (IMAS study) Carlos VallejoAna RosellM. Lorena Codesido Original Article 04 January 2024 Pages: 705 - 713
A convenient and practical index for predicting the induction response in adult patients with hemophagocytic lymphohistiocytosis: ferritin/platelet ratio Cuicui FengZhengjie HuaYini Wang Original Article Open access 10 January 2024 Pages: 715 - 723
Largest comparison between onset and relapses of acquired thrombotic thrombocytopenic purpura reveals severe neurological involvement and worse analytic parameters at debut Blanca Vegas VillalmanzoRodrigo Cantera EstefaníaJorge Martínez Nieto Research 27 January 2024 Pages: 725 - 727
Clinical characteristics of SARS-CoV-2 Omicron variant infection in children with acute leukemia Pengli HuangHenghui ChangHuyong Zheng Original Article 28 December 2023 Pages: 729 - 736
Genomic classification and outcomes of young patients with polycythemia vera and essential thrombocythemia according to the presence of splanchnic vein thrombosis and its chronology Marta GarroteMónica López-GuerraAlberto Alvarez-Larrán Original Article Open access 24 January 2024 Pages: 737 - 747
Relapse and transformation to myelodysplastic syndrome and acute myeloid leukemia following immunosuppressive therapy for aplastic anemia is more common as compared to allogeneic stem cell transplantation with a negative impact on survival Sohini ChattopadhyaySharon LionelBiju George Original Article 20 January 2024 Pages: 749 - 758
Hypomethylating agent monotherapy in core binding factor acute myeloid leukemia: a French multicentric retrospective study Ludovic GabellierPierre PeterlinEmmanuel Raffoux Original Article Open access 26 January 2024 Pages: 759 - 769
Effect of low skeletal muscle mass on NK cells in patients with acute myeloid leukemia and its correlation with prognosis Jialin CuiMiaomiao ZhaoQian Sun Original Article 31 January 2024 Pages: 771 - 780
CXC chemokine ligand 13 and galectin-9 plasma levels collaboratively provide prediction of disease activity and progression-free survival in chronic lymphocytic leukemia Heba A. AhmedAsmaa NafadyAhmed Ahmed Allam Original Article Open access 09 November 2023 Pages: 781 - 792
Tislelizumab monotherapy in patients with previously untreated early-stage classical Hodgkin lymphoma: a real-world study Peng SunHang YangZhiming Li Original Article 13 November 2023 Pages: 793 - 801
Diffuse large B cell lymphoma characteristics and outcomes during the COVID-19 pandemic in two tertiary centers - an Israeli/ Italian study Odil GiladiGianmarco BagnatoRonit Gurion Original Article 11 November 2023 Pages: 803 - 811
A different perspective on PET/CT before treatment in patients with Hodgkin lymphoma: importance of volumetric and dissemination parameters Ayşegül AksuKadir Alper KüçükerBülent Turgut Original Article 15 November 2023 Pages: 813 - 822
Evaluation of the cachexia index using a bioelectrical impedance analysis in elderly patients with non-Hodgkin’s lymphoma: A single-center prospective study So OkuboKohei ShinmuraTomonori Nakazato Original Article 27 November 2023 Pages: 823 - 831
NOTCH pathway mutation contributes to inferior prognosis in HBV-infected chronic lymphocytic leukemia Chun-Yu ShangLi-Ye BeiWei Xu Original Article 23 November 2023 Pages: 833 - 841
Reduced-intensity allogenic transplantation for children and adolescents with Philadelphia chromosome-positive acute lymphoblastic leukemia Hisashi IshidaYuki ArakawaToshihiko Imamura Original Article 25 November 2023 Pages: 843 - 854
Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trial Huixing ZhouYafei WangWenming Chen Original Article Open access 19 December 2023 Pages: 855 - 868
Clinical significance and predictive risk factors for event-free survival at 24 months in patients with PTCL, NOS Zheng CaoXiaojun WangXiaoli Feng Original Article 01 December 2023 Pages: 869 - 883
Appropriate timing to perform an interim 18F-FDG PET/CT in patients with nasal-type extranodal natural killer/T cell lymphoma Rang WangYue ZhangMinggang Su Original Article 30 November 2023 Pages: 885 - 892
Optimal dosage of rituximab for children with Burkitt lymphoma Shuang HuangLing JinHuyong Zheng Original Article 13 December 2023 Pages: 893 - 903
Comprehensive analysis of orbital lymphoma in a Turkish cohort: clinical characteristics, histological subtypes, treatment modalities, prognostic factors, and implications for management Arif AkyildizRashad IsmayilovIbrahim Barista Original Article 07 December 2023 Pages: 905 - 915
The indirect effects of CMV reactivation on patients following allogeneic hematopoietic stem cell transplantation: an evidence mapping Xiaojin WuXiao MaDepei Wu Original Article Open access 16 January 2024 Pages: 917 - 933
Clinical characteristics and outcomes of Epstein-Barr virus viral load after allogeneic hematopoietic stem cell transplantation Takafumi TsushimaShin-Ichi MasudaNobuyuki Aotsuka Original Article Open access 29 December 2023 Pages: 935 - 946
Efficacy and safety of biosimilar Peg-filgrastim after autologous stem cell transplant in myeloma and lymphoma patients: a comparative study with biosimilar Filgrastim, Lenograstim, and originator Peg-filgrastim Francesco MarchesiIrene TerrenatoAndrea Mengarelli Original Article Open access 08 January 2024 Pages: 947 - 956
Temporal trends in critical care utilization and outcomes in allogeneic hematopoietic stem cell transplant recipients Kiyan HeybatiDomenic OchalHemang Yadav Original Article 03 January 2024 Pages: 957 - 967
Modified EASIX scores predict severe CRS/ICANS in patients with acute myeloid leukemia following CLL1 CAR-T cell therapy Yifan ZhaoXiaomei ZhangMingfeng Zhao Original Article 12 January 2024 Pages: 969 - 980
Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study Ivo DemelDavid SkopalRoman Hájek Original Article Open access 14 December 2023 Pages: 981 - 992
VEXAS syndrome: complete molecular remission after hypomethylating therapy Katja SockelKatharina GötzeChristian Thiede Case Report Open access 12 January 2024 Pages: 993 - 997
Low-dose venetoclax combined with azacitidine for blastic plasmacytoid dendritic cell neoplasm: a case report and literature review Qiuyan WangYajing ZhaoChuanfang Liu Case Report 29 January 2024 Pages: 999 - 1005
Warm autoimmune hemolytic anemia associated with SARS-CoV-2 infection responsive to eculizumab Yuemin GongXinyu ZhangJianyong Li Letter to the Editor 27 November 2023 Pages: 1007 - 1009
Diamond-Blackfan anemia with very late and fatal onset aplasia in a 55-year-old patient with RPL11 mutation Bernhard StrasserSonja HeiblAlexander Haushofer Letter to the Editor 23 November 2023 Pages: 1011 - 1012
Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management John Donald MarraFilippo FrioniPatrizia Chiusolo Letter to the Editor 29 November 2023 Pages: 1013 - 1014
Heavily pretreated patient with nodal marginal zone lymphoma successfully treated with mosunetuzumab Marko LucijanicAnica SabljicRajko Kusec Letter to the Editor 25 November 2023 Pages: 1015 - 1016
Refractory hemophagocytic lymphohistiocytosis secondary to polatuzumab vedotin plus rituximab and bendamustine Kebing LvFancong KongFei Li Letter to the Editor Open access 29 December 2023 Pages: 1017 - 1019
Small lymphocytic lymphoma infiltrating gastrointestinal tract and mimicking inflammatory bowel disease, successfully treated with acalabrutinib Ivan KrečakEva ČubrićMarko Skelin Correspondence 15 December 2023 Pages: 1021 - 1023
Acute liver injury after SARS-CoV-2 vaccination and luspatercept administration in a patient with β-thalassemia Simona LeoniRayan Bou-FakhredinIrene Motta LETTER TO THE EDITOR 03 January 2024 Pages: 1025 - 1026
Philadelphia chromosome-positive B cell acute lymphoblastic phase arising 24 years after treatment-free remission for chronic myeloid leukemia with identical BCR-ABL fusion transcript Julien DeremeSophie VoruzSabine Blum Letter to the Editor 09 January 2024 Pages: 1027 - 1029
Midostaurin for FLT3-mutated AML: a real-world analysis of effectiveness and infection risk at a single center Alice KennedyShyam PatelJan Cerny Letter to the Editor 09 January 2024 Pages: 1031 - 1033